Dr. Reddy's Laboratories Limited (RDY)

NYQ – Real Time Price. Currency in USD

15.38

+0.13 (0.85%)

At close: Jun 26, 2026, 4:00 PM EDT

15.32

-0.06 (-0.39%)

After-hours: Jun 26, 2026, 6:40 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

3.80B

3.85B

3.37B

3.06B

Cost of goods sold

-1.80B

-1.72B

-1.49B

-1.41B

Gross Profit

2.01B

2.13B

1.88B

1.65B

Operating expenses (excl. COGS)

-1.48B

-1.31B

-1.11B

-1B

Operating Income

526M

822M

772M

650M

Non-operating income, total

93M

84M

95M

97M

Pretax income

619M

906M

866M

747M

Equity in earnings

Taxes

-140M

-231M

-196M

-190M

Non-controlling/minority interest

-8M

After tax other income/expense

Net income before discontinued operations

485M

669M

673M

561M

Dr. Reddy's Laboratories Limited (RDY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dr. Reddy's Laboratories Limited (RDY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Dr. Reddy's Laboratories Limited (RDY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Dr. Reddy's Laboratories Limited (RDY)

Income Statement (Annual)

Income Statement (Annual)